For instance, hypermethylation of the promoters of human equilibrative nucleoside transporter 1 (hENT1) and deoxycytidine kinase (dCK) confers gemcitabine resistance in cervical cancer [43]. The gene discussed is SLC29A1; the disease is cervical cancer.